Clinical Trial Update: IPT of Malaria With SP in Different Zones of Drug Resistance in Rwanda [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intermittent preventive therapy for malaria with sulfadoxine-pyrimethamine in HIV-negative pregnant women in Rwanda has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Fansidar (sulfadoxine-pyrimethamine)
• Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Non HIV Infected Pregnant Women | Phase 4 | Status: COMPLETED